Prurigo nodularis : Pathogenesis and management - 09/11/20
Abstract |
Prurigo nodularis is a chronic skin condition characterized by severely pruritic nodules that cause a profound negative impact on quality of life. The second article in this 2-part continuing medical education series focuses on reviewing the pathogenesis of prurigo nodularis and exploring management algorithms for this condition. In addition, we discuss some emerging and novel therapies for treating prurigo nodularis. The first article in this 2-part series describes the broader epidemiology, patient demographics, physical examination findings, and symptoms to aid in the timely recognition and diagnosis of prurigo nodularis.
Le texte complet de cet article est disponible en PDF.Key words : antipruritic, clinical features, itch, management, pathogenesis, prurigo nodularis, pruritus, therapeutics
Plan
| Funding sources: Dr Kwatra received grant funding from the Skin of Color Society and is a recipient of the Dermatology Foundation Medical Dermatology Career Development Award. |
|
| Date of release: December 2020. |
|
| Expiration date: December 2023. |
|
| Conflicts of interest: Dr Kwatra is an advisory board member for Pfizer Inc, Regeneron Pharmaceuticals, and Menlo Therapeutics and has received grant funding from Pfizer and Kiniksa Pharmaceuticals. The other authors involved with this journal-based CME activity have reported no relevant financial relationships with commercial interest(s). |
Vol 83 - N° 6
P. 1567-1575 - décembre 2020 Retour au numéro
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?